Clinical trial medicine cabinet and clinical trial medicine management method

Abstract

This invention discloses a clinical trial drug cabinet and a clinical trial drug management method. The clinical trial drug cabinet includes a connected cabinet body and a cabinet door, with the interior of the cabinet body and the cabinet door forming a storage space. A weighing platform divides the storage space into multiple layers of clinical trial drug storage spaces. Each layer of clinical trial drug storage space is equipped with an electronic tag reader. By cooperating with the weighing platform and the electronic tag reader, it is possible to determine which clinical trial drug is currently being placed in or taken out of the cabinet, as well as the original storage space where the clinical trial drug was placed, or from which clinical trial drug was taken out. This effectively avoids drug management chaos and improves drug storage and retrieval efficiency.

Description

Technical Field

[0001] This invention relates to the field of technology, and in particular to a clinical trial drug cabinet and a method for managing clinical trial drugs. Background Technology

[0002] Clinical trial drug cabinets are used to store clinical trial drugs. They have a relatively large internal space and are generally divided into multiple layers. Each layer contains a variety of clinical trial drugs, and because drugs are frequently retrieved or put back into the cabinet, the clinical trial drugs in each layer often change.

[0003] Due to the special nature of clinical trials, drugs used in clinical trials require rigorous experimental conditions. The storage temperature of these drugs is very strict, as temperature has a significant impact on their metabolism. Therefore, frequent opening and closing of doors or prolonged periods of time when searching for drugs result in significant temperature loss. For these reasons, doctors may not know which shelf a drug is on when retrieving or placing it in a cabinet. The entire process requires manual searching, leading to long opening times and low efficiency. Summary of the Invention

[0004] Therefore, it is necessary to provide clinical trial drug cabinets and clinical trial drug management methods to solve the problem of low efficiency in clinical trial drug management.

[0005] A clinical trial drug cabinet includes a connected cabinet body and a cabinet door, the interior of the cabinet body and the cabinet door forming a receiving space;

[0006] The inner wall of the cabinet is fixedly connected to multiple weighing platforms that pass through the storage space, and each weighing platform is set perpendicular to the cabinet door, dividing the storage space into multiple layers of clinical trial drug storage space.

[0007] Each layer of clinical trial drug storage space is equipped with at least one electronic tag reader for scanning the electronic tags attached to clinical trial drugs.

[0008] In one embodiment, each weighing platform includes a carrier plate fixedly connected to the inner wall of the cabinet, a weighing sensor disposed at the bottom of the carrier plate, and an access display disposed on the carrier plate near the cabinet door.

[0009] In one embodiment, the electronic tag reader is symmetrically arranged on two side walls inside the cabinet, the two side walls being perpendicular to the weighing platform and the cabinet door.

[0010] In one embodiment, the cabinet is also equipped with a refrigerant, a temperature sensor, a humidity regulator, and a humidity sensor.

[0011] In one embodiment, the waist of the cabinet is also provided with a partition that runs through the accommodating space, and the partition is arranged parallel to the weighing platform, and the partition divides the accommodating space into a first accommodating space and a second accommodating space.

[0012] The cabinet door includes a first cabinet door and a second cabinet door. The first cabinet door is used to open or close the first accommodating space, and the second cabinet door is used to open or close the second accommodating space.

[0013] An environmental display for displaying temperature and / or humidity is provided at one end of the partition near the cabinet door, and is connected to the temperature sensor and the humidity sensor.

[0014] A method for managing clinical trial drugs, applied to the aforementioned clinical trial drug cabinet, the method comprising:

[0015] After receiving the list of clinical trial drugs to be placed in the cabinet from the pharmacy system, when receiving the cabinet placement instruction associated with the clinical trial drug to be placed in the cabinet, the system searches for the target storage space of the clinical trial drug to be placed in the cabinet list based on the cabinet placement instruction and provides a prompt.

[0016] When the electronic tag reader in the storage space scans the electronic tag attached to the clinical trial drug to be placed in the storage space, it reads the clinical trial drug information recorded in the electronic tag; wherein, the storage space is any layer in the multi-layer clinical trial drug storage space;

[0017] Determine whether the clinical trial drug information of the drug to be placed in the cabinet is included in the clinical trial drug placement list;

[0018] If the clinical trial drug information of the drug to be placed in the cabinet is not included in the clinical trial drug placement list, an abnormality prompt will be issued;

[0019] If the clinical trial drug information of the clinical trial drug to be placed in the cabinet is included in the clinical trial drug cabinet list, then after the weighing platform in the cabinet storage space detects an increase in the weight it bears, it is determined whether the target storage space is consistent with the cabinet storage space.

[0020] If the target storage space is inconsistent with the cabinet storage space, a prompt will be given regarding the target storage space;

[0021] If the target storage space matches the cabinet storage space, then the clinical trial drug to be cabineted is successfully cabineted.

[0022] In one embodiment, the method further includes:

[0023] After receiving the list of clinical trial drugs sent by the pharmacy system, the current placement list of the clinical trial drug cabinet is obtained; wherein, the current placement list records the current storage space of all clinical trial drugs in the clinical trial drug cabinet;

[0024] By comparing the clinical trial drug retrieval list with the current placement list, the retrieval storage space where the clinical trial drug to be retrieved is placed can be determined from all clinical trial drug storage spaces and a prompt can be made.

[0025] If the weighing platform in the drug retrieval storage space detects a decrease in the weight it carries, the electronic tag reader in the drug retrieval storage space scans the electronic tag attached to the clinical trial drug to be retrieved to read the clinical trial drug information of the clinical trial drug to be retrieved; wherein, the drug retrieval storage space is any layer in the multi-layer clinical trial drug storage space;

[0026] If the clinical trial drug information is included in the clinical trial drug collection list, then the collection of the clinical trial drug will be successful.

[0027] In one embodiment, the step of comparing the clinical trial drug retrieval list and the current placement list to determine the retrieval storage space where the clinical trial drug to be retrieved is placed among all clinical trial drug storage spaces and then providing a prompt includes:

[0028] After comparing the clinical trial drug retrieval list and the current placement list, if it is determined that a clinical trial drug to be retrieved is placed in a multi-layer clinical trial drug storage space, the clinical trial drug storage space where the clinical trial drug to be retrieved with the closest expiration date is placed will be used as the drug retrieval storage space and a prompt will be made.

[0029] In one embodiment, the method further includes:

[0030] After comparing the clinical trial drug retrieval list with the current placement list, if it is determined that there are multiple clinical trial drugs to be retrieved in the same layer of clinical trial drug storage space, the retrieval of the clinical trial drug to be retrieved will be successful when the clinical trial drug closest to its expiration date is retrieved.

[0031] In one embodiment, the step of comparing the clinical trial drug retrieval list and the current placement list to determine the retrieval storage space where the clinical trial drug to be retrieved is placed among all clinical trial drug storage spaces and then providing a prompt includes:

[0032] After comparing the clinical trial drug retrieval list and the current placement list, if it is determined that multiple clinical trial drugs to be retrieved are placed in the multi-layer clinical trial drug storage space, the clinical trial drug storage space containing the most clinical trial drugs to be retrieved will be designated as the drug retrieval storage space in real time and a prompt will be given.

[0033] This invention provides a clinical trial drug cabinet and a clinical trial drug management method. The cabinet is divided into multiple layers of clinical trial drug storage space by a weighing platform. The combination of the weighing platform and an electronic tag reader can determine which clinical trial drug is currently being placed in or taken out of the cabinet. It can also determine the original clinical trial drug storage space where the clinical trial drug was placed, or from which clinical trial drug storage space the clinical trial drug was taken out. This can effectively avoid drug management chaos and improve drug storage and retrieval efficiency. Attached Figure Description

[0034] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.

[0035] in:

[0036] Figure 1 This is a schematic diagram of the first structure of a clinical trial drug cabinet.

[0037] Figure 2 This is a diagram of the electronic tag affixed to a drug used in clinical trials.

[0038] Figure 3 A schematic diagram of the clinical trial drug storage space on each floor;

[0039] Figure 4 This is a schematic diagram of the second structure of the clinical trial drug cabinet;

[0040] Figure 5 This is a schematic diagram of the clinical trial drug management method in the first embodiment;

[0041] Figure 6 This is a schematic diagram of the clinical trial drug management method in the second embodiment. Detailed Implementation

[0042] The technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.

[0043] The terms "first," "second," etc., in the specification, claims, and accompanying drawings of this application are used to distinguish different objects, not to describe a specific order. Furthermore, the terms "comprising" and "having," and any variations thereof, are intended to cover non-exclusive inclusion. For example, a process, method, system, product, or apparatus that includes a series of steps or units is not limited to the listed steps or units, but may optionally include steps or units not listed, or may optionally include other steps or units inherent to these processes, methods, products, or apparatuses.

[0044] In this document, the term "embodiment" means that a particular feature, structure, or characteristic described in connection with an embodiment may be included in at least one embodiment of this application. The appearance of this phrase in various places throughout the specification does not necessarily refer to the same embodiment, nor is it a separate or alternative embodiment mutually exclusive with other embodiments. It will be explicitly and implicitly understood by those skilled in the art that the embodiments described herein can be combined with other embodiments.

[0045] Good Clinical Practice (GCP) is the fundamental principle of drug clinical trial management. It is a set of standard requirements established to ensure the scientific rigor, ethical integrity, and quality of clinical trials. To comply with this standard, the following clinical trial drug cabinet and clinical trial drug management methods have been designed.

[0046] like Figure 1 As shown, Figure 1 This is a first structural schematic diagram of a clinical trial drug cabinet. In this embodiment, the clinical trial drug cabinet includes a connected cabinet body 100 and a cabinet door 200, wherein the interior of the cabinet body 100 and the cabinet door 200 form a receiving space A.

[0047] Multiple weighing platforms 300 are fixedly connected to the inner wall of the cabinet 100, forming a continuous storage space A. Each weighing platform 300 is perpendicular to the cabinet door 200, dividing the storage space A into multiple layers of clinical trial drug storage space. Figure 1The system includes six weighing platforms 300, dividing the storage space A into seven layers (a1-a7). A1-a6 serve as storage spaces for clinical trial drugs, with each layer capable of holding a specific quantity and type of clinical trial drug. A7 is used for storing other necessary equipment. It is understood that the number and spacing of the weighing platforms 300 can be customized according to actual needs and are not specifically limited here.

[0048] When a clinical trial drug is placed on any of the weighing platforms 300, or taken out from any of the weighing platforms 300, the corresponding weighing platform 300 will detect the change in weight, thereby determining the original clinical trial drug storage space where the clinical trial drug was placed, or determining from which clinical trial drug storage space the clinical trial drug was taken out.

[0049] In addition, each layer of clinical trial drug storage space is equipped with at least one electronic tag reader 400 for scanning the electronic tags affixed to the clinical trial drugs. For example, the electronic tag reader 400 can be a Radio Frequency Identification (RFID) reader. The electronic tags affixed to the clinical trial drugs are, for example... Figure 2 As shown, the information on clinical trial drugs, including commodity codes, product names, expiration dates, and batch numbers, is affixed with a unique code for each drug to distinguish them. When a clinical trial drug enters or is retrieved from any clinical trial drug storage space, the corresponding electronic tag reader 400 scans the electronic tag attached to the clinical trial drug to read its information and determine which specific clinical trial drug has been placed or retrieved. This prevents confusion in drug management and improves drug storage and retrieval efficiency.

[0050] It is evident that the aforementioned clinical trial drug cabinet can identify which clinical trial drug is currently being placed in or retrieved, as well as the original storage space where the clinical trial drug was placed, or from which storage space the clinical trial drug was retrieved. This effectively avoids drug management chaos and improves drug storage and retrieval efficiency.

[0051] Furthermore, the design and use of this clinical trial drug cabinet can ensure the quality and safety of investigational drugs, and comply with the GCP principles that require investigational drugs to be produced, managed and stored in accordance with the current Good Manufacturing Practice (GMP) for pharmaceuticals.

[0052] The weighing platform and electronic tag reader of the clinical trial drug cabinet can effectively record, process and store clinical trial data, including information such as the quantity, batch number, expiration date and allocation code of the investigational drug, which complies with the GCP principle that all clinical trial data should be recorded, processed and stored in a manner that ensures its accurate reporting, interpretation and verification.

[0053] The electronic tag reader for clinical trial drug cabinets can achieve a one-item-one-code affixing method, avoiding drug management chaos, improving drug storage and retrieval efficiency, and meeting the requirements of GCP principles that clinical trials should have good scientific rigor and should be clearly and thoroughly described in the trial protocol.

[0054] Furthermore, in one specific embodiment, each weighing platform 300 includes a carrier plate 310 fixedly connected to the inner wall of the cabinet 100, a weighing sensor 320 disposed at the bottom of the carrier plate 310, and an access display 330 disposed at one end of the carrier plate 310 near the cabinet door 200. The carrier plate 310 is a plane extending through the accommodating space A, on which clinical trial drugs can be placed directly. When clinical trial drugs are placed into or removed from the cabinet, the weighing sensor 320 can sense the weight change on the carrier plate 310, thereby identifying whether a clinical trial drug placement or removal operation is being performed. Furthermore, the access display 330, in conjunction with the weighing sensor 320, can display the weight change of the drug on the carrier plate 310, such as how much the current weight has increased or decreased. Furthermore, since different types of drugs have different standard weights, based on the current weight change, the access display 330 can also display the specific clinical trial drug currently placed into or removed from the cabinet. For example, the weight of clinical trial drug D1 is N1, and the weight of clinical trial drug D2 is N2. Furthermore, the access display 330 can also provide a prompt before the drug is placed in or retrieved, for example, by flashing or remaining constantly lit, thus indicating to the pharmacist that the correct clinical trial drug storage space corresponds to one or more access displays 330.

[0055] Furthermore, in one specific embodiment, such as Figure 3 As shown, electronic tag readers 400 are symmetrically arranged on two side walls inside the cabinet 100, perpendicular to the weighing platform 300 and the cabinet door 200. Each electronic tag reader 400 should cover as much of the clinical trial drug storage space as possible. This way, once a clinical trial drug enters or leaves the clinical trial drug storage space, the electronic tag reader 400 can promptly read its clinical trial drug information, thereby identifying whether the actions of taking away and putting in clinical trial drugs are consistent with the system allocation, ensuring accuracy.

[0056] Furthermore, in one specific embodiment, the cabinet 100 also includes a refrigerant, a temperature sensor, a humidity regulator, and a humidity sensor. For example... Figure 1 As shown, these devices can all be installed within storage space a7. The cooler controls the temperature inside the cabinet, maintaining it within a reasonable range, generally between 2 and 8 degrees Celsius. This is monitored by a temperature sensor; when the temperature exceeds this range, a signal is sent to a mobile terminal, such as the pharmacist's phone or computer. The humidity regulator controls the humidity inside the cabinet, maintaining it within a reasonable range, generally between 35% and 75%. This is also monitored by a humidity sensor; when the humidity exceeds this range, a signal is sent to a mobile terminal, such as the pharmacist's phone or computer.

[0057] Furthermore, in one specific embodiment, such as Figure 4 As shown, Figure 4 This is a second structural diagram of a clinical trial drug cabinet. The cabinet body 100 also features a partition 500 that extends through the storage space. This partition 500 is parallel to the weighing platform 300 and divides the storage space into a first storage space A1 and a second storage space A2. The cabinet doors include a first door 210 and a second door 220. The first door 210 is used to open or close the first storage space A1, and the second door 220 is used to open or close the second storage space A2. An environmental display for displaying temperature and / or humidity is located near the cabinet door end of the partition 500 and is connected to a temperature sensor and a humidity sensor.

[0058] In this way, the storage space is further subdivided into a first storage space A1 and a second storage space A2, allowing for more precise placement of clinical trial drugs. For example, for a batch of clinical trial drugs: D1-D10, E1-E10, during the cabinet placement operation, the system can prompt the pharmacist to place D1-D10 in the first storage space A1 and E1-E10 in the second storage space A2. During the drug retrieval operation, if the input retrieval command is related to D1, only the first cabinet door 210 needs to be opened, without opening the second cabinet door 220. This also facilitates the pharmacist's search for clinical trial drugs and improves drug retrieval efficiency.

[0059] Furthermore, in one specific embodiment, such as Figure 4 As shown, a monitor 600 is also installed on the cabinet 100. The monitor 600 is used to monitor the actions of the person picking up the medicine so as to facilitate subsequent traceability and inquiry.

[0060] like Figure 5 As shown, Figure 5This is a flowchart illustrating the clinical trial drug management method in the first embodiment. This method is applied to the aforementioned clinical trial drug cabinet. The steps provided by the clinical trial drug management method in this embodiment include:

[0061] S501, after receiving the list of clinical trial drugs to be placed in the cabinet from the pharmacy system, when it receives the cabinet placement instruction associated with the clinical trial drug to be placed in the cabinet, searches for the target storage space of the clinical trial drug to be placed in the cabinet in the cabinet list based on the cabinet placement instruction and provides a prompt.

[0062] Specifically, before placing a clinical trial drug into the cabinet, the pharmacy system sends a list of drugs to be placed to the clinical trial drug cabinet. For example, a list might include drugs D1-D10 and their corresponding storage spaces. After the operator retrieves the electronically tagged clinical trial drug, they click the "place" command on the cabinet, view the list, and select the drug to be placed. The cabinet then searches for the target storage space based on the entered list and displays a notification. For instance, if drug D1 is currently to be placed, and the list indicates it should be placed in target storage space a1, the cabinet door will open, and target storage space a1 will provide a notification, such as a voice announcement or a flashing light. With this notification, the pharmacist can easily place the corresponding clinical trial drug.

[0063] s502 When the electronic tag reader in the storage space scans the electronic tag attached to the clinical trial drug to be placed in the cabinet, it reads the clinical trial drug information recorded in the electronic tag.

[0064] The cabinet storage space can be any layer in the multi-layer clinical trial drug storage space.

[0065] Specifically, the signal distribution emitted by the electronic tag reader creates a coordinate system within the cabinet, dividing the cabinet space into multiple areas, such as... Figure 1 As shown, a1-a6 are storage spaces for clinical trial drugs. The working area of ​​the electronic tag reader includes the weighing platform corresponding to each layer. When a clinical trial drug with an electronic tag enters this area, it will automatically sense which layer it has entered, thus identifying which layer the clinical trial drug has entered, sending a signal and recording it. For example, if the clinical trial drug actually enters clinical trial drug storage space a1, then a1 is the cabinet storage space; if the clinical trial drug actually enters clinical trial drug storage space a2, then a2 is the cabinet storage space, and a signal is sent and recorded.

[0066] S503: Determine whether the clinical trial drug information of the drug to be placed in the cabinet is included in the clinical trial drug cabinet list; if the clinical trial drug information of the drug to be placed in the cabinet is not included in the clinical trial drug cabinet list, then execute S504; if the clinical trial drug information of the drug to be placed in the cabinet is included in the clinical trial drug cabinet list, then execute S505.

[0067] For example, if the clinical trial drug information for a drug to be placed in the cabinet is E1, but the clinical trial drug information recorded in the clinical trial drug placement list only includes D1-D10, then the clinical trial drug placed in the cabinet is incorrect, and s504 is executed in this case; if the clinical trial drug information for a drug to be placed in the cabinet is D1, then the clinical trial drug placed in the cabinet is correct, and s505 is executed in this case.

[0068] S504 indicates an error.

[0069] s505: After the weighing platform in the cabinet storage space detects an increase in the weight it is carrying, determine whether the target storage space is consistent with the cabinet storage space. If the target storage space is inconsistent with the cabinet storage space, execute s506. If the target storage space is consistent with the cabinet storage space, execute s507.

[0070] Specifically, after the clinical trial drug enters the work area, it will only be detected by the weighing platform when placed on it. The platform will then send the signal to the system. When the system detects the simultaneous presence of both signals, it will determine the target storage space and the cabinet storage space. If the target storage space and the cabinet storage space are inconsistent, it indicates an incorrect placement, and step s506 is executed; if they are consistent, it indicates correct placement, and step s507 is executed.

[0071] Conversely, if only the signal from the electronic tag reader is detected, but the signal from the weighing platform is not detected, no record will be made. For example, if the operator only inserts the clinical trial drug into the weighing platform and then takes it out without placing it in the platform.

[0072] s506 provides a prompt regarding the target storage space.

[0073] S507 indicates that the clinical trial drug awaiting warehousing has been successfully warehousing.

[0074] The above-mentioned clinical trial drug management method can not only identify which clinical trial drug is currently placed in the cabinet, but also determine the original storage space where the clinical trial drug was originally placed, which can effectively avoid drug management chaos and improve the efficiency of drug placement.

[0075] Similarly, the design and use of clinical trial drug management methods can ensure the quality and safety of investigational drugs, and comply with the requirements of GCP principles that investigational drugs should be produced, managed and stored in accordance with the current Good Manufacturing Practice (GMP) for pharmaceuticals.

[0076] Electronic tag readers and weighing stations used in clinical trial drug management methods can effectively record, process, and store clinical trial data, including information such as the quantity, batch number / serial number, expiration date, and allocation code of the investigational drug. This complies with the GCP principle that all clinical trial data should be recorded, processed, and stored in a manner that ensures accurate reporting, interpretation, and verification.

[0077] Abnormal alerts and target storage space prompts in clinical trial drug management methods can prevent drug management chaos, improve drug storage efficiency, and comply with the GCP principles that clinical trials should have good scientific rigor and should be clearly and thoroughly described in the trial protocol.

[0078] like Figure 6 As shown, Figure 6 This is a flowchart illustrating the clinical trial drug management method in the second embodiment. This method is applied to the aforementioned clinical trial drug cabinet. The steps provided by the clinical trial drug management method in this embodiment include:

[0079] S501, after receiving the list of clinical trial drugs to be placed in the cabinet from the pharmacy system, when it receives the cabinet placement instruction associated with the clinical trial drug to be placed in the cabinet, searches for the target storage space of the clinical trial drug to be placed in the cabinet in the cabinet list based on the cabinet placement instruction and provides a prompt.

[0080] s502 When the electronic tag reader in the storage space scans the electronic tag attached to the clinical trial drug to be placed in the cabinet, it reads the clinical trial drug information recorded in the electronic tag.

[0081] S503: Determine whether the clinical trial drug information of the drug to be placed in the cabinet is included in the clinical trial drug cabinet list; if the clinical trial drug information of the drug to be placed in the cabinet is not included in the clinical trial drug cabinet list, then execute S504; if the clinical trial drug information of the drug to be placed in the cabinet is included in the clinical trial drug cabinet list, then execute S505.

[0082] S504 indicates an error.

[0083] s505: After the weighing platform in the cabinet storage space detects an increase in the weight it is carrying, determine whether the target storage space is consistent with the cabinet storage space. If the target storage space is inconsistent with the cabinet storage space, execute s506. If the target storage space is consistent with the cabinet storage space, execute s507.

[0084] s506 provides a prompt regarding the target storage space.

[0085] S507 indicates that the clinical trial drug awaiting warehousing has been successfully warehousing.

[0086] In the second embodiment, s501-s507 of the clinical trial drug management method are basically the same as s501-s507 of the first embodiment, so they will not be described again.

[0087] After receiving the list of clinical trial drugs from the pharmacy system, s508 retrieves the current placement list of the clinical trial drug cabinet.

[0088] The current placement list records the storage space where all clinical trial drugs are currently placed in the clinical trial drug cabinet. For example, clinical trial drug D1 is placed in clinical trial drug storage space a1, and clinical trial drug D2 is placed in clinical trial drug storage space a2.

[0089] S509 identifies the storage space where the clinical trial drug to be retrieved is located by comparing the clinical trial drug retrieval list with the current placement list and provides a prompt.

[0090] Specifically, during medication dispensing, the pharmacy system first sends the clinical trial drug dispensing list for the subject and the investigational drug to the clinical trial drug cabinet. When the pharmacist dispenses the medication, they click on the prescription list, the cabinet door opens, and by comparing the clinical trial drug dispensing list with the current storage list, the system identifies the storage space where the clinical trial drug to be dispensed is located among all the clinical trial drug storage spaces and provides a prompt. This facilitates searching on that floor and improves search efficiency.

[0091] For example, if the previous placement list records that clinical trial drug D1 is placed in clinical trial drug storage space a1 and clinical trial drug D2 is placed in clinical trial drug storage space a2, and the list of drugs to be retrieved records that clinical trial drug D1 is to be retrieved, then the corresponding storage space a1 will be used for prompting, such as a voice prompt or a flashing light in area a1; if the list of drugs to be retrieved records that both clinical trial drugs D1 and D2 are to be retrieved, then the corresponding storage spaces a1 and a2 will be used for prompting. Furthermore, when retrieving drugs, there is a distinction between randomly selected and non-randomized drugs. For example, if multiple boxes of drug A are stored in the cabinet, if it is a randomly selected drug, any one can be retrieved; if it is a non-randomized drug, the drug with the corresponding electronic tag code will be retrieved.

[0092] In one specific embodiment, the prompt can also be made in the following way: after comparing the clinical trial drug retrieval list and the current placement list, if it is determined that a clinical trial drug to be retrieved is placed in the multi-layer clinical trial drug storage space, the clinical trial drug storage space where the clinical trial drug to be retrieved with the closest expiration date is placed is used as the drug retrieval storage space and a prompt is made.

[0093] For example, if there are multiple boxes of clinical trial drug D1 to be retrieved, and they are distributed in different layers, such as a1 and a2, and the drug to be retrieved is random, and any box can be retrieved, then before allocating the location, the system determines which D1 in a1 and a2 is closest to the expiration date. If the D1 in a1 is closest to the expiration date, then a1 is given priority as the drug retrieval storage space.

[0094] In another specific embodiment, the prompt can also be made in the following way: after comparing the clinical trial drug retrieval list and the current placement list, if it is determined that there are multiple clinical trial drugs to be retrieved in the same layer of clinical trial drug storage space, until the clinical trial drug with the closest expiration date is retrieved, the prompt will indicate that the clinical trial drug to be retrieved has been successfully retrieved.

[0095] For example, if the drug to be retrieved is D1, and there are 10 boxes in the same clinical trial drug storage space a1, assuming that the production dates are different and the numbers are 1-10, and the drug to be retrieved is a random drug, then the system determines which D1 among the numbers 1-10 is closest to the expiration date before allocating the location. If the D1 with number 1 is closest to the expiration date, then a1 is given priority as the drug retrieval storage space.

[0096] Furthermore, the two specific embodiments described above prioritize the medicine with the closest expiration date. Other priorities can be extended based on this, such as: first priority: medicine with the closest expiration date is taken out first; second priority: medicine that entered the medicine cabinet first is taken out first; third priority: medicine with the heaviest weight is taken out first.

[0097] In another specific embodiment, the prompt can also be made in the following way: after comparing the list of clinical trial drugs to be picked up with the current placement list, if it is determined that multiple clinical trial drugs to be picked up are placed in the multi-layer clinical trial drug storage space, the clinical trial drug storage space containing the most clinical trial drugs to be picked up is used as the drug picking storage space in real time and a prompt is made.

[0098] For example, if there are multiple drugs (A, B, C) to be retrieved, and these drugs are distributed on different shelves and in multiple boxes, then before the system assigns a location, the order in which the clinical trial drugs are retrieved is sorted, prioritizing the drugs in the same cabinet. If there are three drugs (A, B, C), and a1 contains only AB while a2 contains A, B, C, then only a2 will be used as the storage space for retrieval, and a notification will be given. Of course, if both a1 and a2 contain A, B, C, and C, then the storage space with the closest expiration date will be prioritized for retrieval.

[0099] Alternatively, if there are three drugs, A, B, and C, and a1 contains only AB, a2 contains A, a3 contains B, and a4 contains C, then a1 should be used as the storage space for retrieving the drug and a prompt should be given first, followed by a4 as the storage space for retrieving the drug and a prompt should be given.

[0100] s510 If the weighing platform in the drug dispensing storage space detects a decrease in the weight it carries, the electronic tag reader in the drug dispensing storage space scans the electronic tag attached to the clinical trial drug to be dispensed to read the clinical trial drug information of the clinical trial drug to be dispensed.

[0101] The drug storage space can be any layer in the multi-layer clinical trial drug storage space.

[0102] Specifically, the weighing platform will only sense a signal and send it to the system when the clinical trial drug is removed from the weighing platform. The electronic tag reader in the drug retrieval storage space then scans the electronic tag attached to the clinical trial drug to be retrieved, reads the clinical trial drug information, and sends it to the system. When the system recognizes the presence of both signals, it then determines whether the clinical trial drug information is included in the clinical trial drug retrieval list.

[0103] Furthermore, sometimes the required quantity of a particular clinical trial drug to be removed may be multiple. Since different categories of drugs have different standard weights, the specific clinical trial drug being removed can be determined based on the current weight changes. For example, if at least three doses of drug A are required, the first and second layers will be illuminated. We need to remove two doses from one layer and one dose from the other. When removing the drugs, the weighing sensor will detect a decrease of two doses in the first layer and one dose in the second layer, indicating accurate drug removal. Similarly, if drugs A and B are present, and the first and second layers are illuminated with two different drugs in each layer, we need to remove the corresponding doses from two layers. This can also be verified by checking the weight reduction detected by the weighing sensor. Furthermore, if drugs A*X, B*Y, and C*Z are present, the quantity of drugs removed from each layer is allocated according to the total weight; the quantity removed corresponds to the weight.

[0104] s511 If the clinical trial drug information is included in the clinical trial drug collection list, then the system will indicate that the clinical trial drug collection was successful.

[0105] If the clinical trial drug information is included in the clinical trial drug collection list, it indicates that the current drug collection is incorrect and a message will be displayed indicating that the wrong drug was collected; if the clinical trial drug information is included in the clinical trial drug collection list, it indicates that the current drug collection is correct and a message will be displayed indicating that the clinical trial drug collection was successful.

[0106] The above-mentioned clinical trial drug management method can not only identify which clinical trial drug is being retrieved, but also determine from which clinical trial drug storage space it was retrieved from, effectively avoiding drug management chaos and improving drug retrieval efficiency.

[0107] Furthermore, the aforementioned clinical trial drug cabinet and clinical trial drug management method can also be applied to clinical trial drug recycling scenarios. Specifically, when a clinical trial drug is used up by a subject or the trial ends, and the clinical trial drug needs to be recycled, the system will send a recycling list to the clinical trial drug cabinet according to the progress of the trial. The list includes information on the clinical trial drugs to be recycled and their electronic tag codes. Pharmacists can then place the corresponding labeled clinical trial drugs into the cabinet to complete the recycling process, which facilitates recycling management.

[0108] Specifically, before recycling, click on the list of clinical trial drugs to be recycled. After scanning the code, the system calculates and assigns an address to the recycled drug. If the weighing platform determines which layer of the cabinet has fewer clinical trial drugs, then that layer is assigned to the recycled drug. At this time, the system re-stores a new set of clinical trial drug information and corresponding location data.

[0109] Furthermore, the aforementioned clinical trial drug cabinet and clinical trial drug management methods can also be applied to clinical trial drug return scenarios. Specifically, when the clinical trial drug cabinet receives a list of returned clinical trial drugs from the system, such as a list of recovered clinical trial drugs and a list of expired clinical trial drugs, the system will display the list. Operators can then use the return function to promptly retrieve the recovered and expired clinical trial drugs from the cabinet, facilitating the standardized management of clinical trial drugs within the cabinet and enabling timely cleanup.

[0110] In addition, the clinical trial drug cabinet also has a clinical trial drug traceability function, such as tracing the entire process of the clinical trial drug to understand its history, which can be done by entering the RFID code associated with the clinical trial drug or scanning the electronic tag.

[0111] It should be noted that the above-mentioned clinical trial drug cabinet and clinical trial drug management method belong to a general inventive concept, and the contents of the embodiments of the clinical trial drug cabinet and clinical trial drug management method are applicable to each other.

[0112] Those skilled in the art will understand that all or part of the processes in the methods of the above embodiments can be implemented by a computer program instructing related hardware. This program can be stored in a non-volatile computer-readable storage medium, and when executed, it can include the processes of the embodiments of the above methods. Any references to memory, storage, databases, or other media used in the embodiments provided in this application can include non-volatile and / or volatile memory. Non-volatile memory may include read-only memory (ROM), programmable ROM (PROM), electrically programmable ROM (EPROM), electrically erasable programmable ROM (EEPROM), or flash memory. Volatile memory may include random access memory (RAM) or external cache memory. By way of illustration and not limitation, RAM is available in various forms, such as static RAM (SRAM), dynamic RAM (DRAM), synchronous DRAM (SDRAM), dual data rate SDRAM (DDRSDRAM), enhanced SDRAM (ESDRAM), synchronous link DRAM (SLDRAM), RAMbus direct RAM (RDRAM), direct memory bus dynamic RAM (DRDRAM), and RAMbus dynamic RAM (RDRAM), etc.

[0113] The technical features of the above embodiments can be combined in any way. For the sake of brevity, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0114] The above embodiments merely illustrate several implementation methods of this application, and while the descriptions are relatively specific and detailed, they should not be construed as limiting the scope of this patent application. It should be noted that those skilled in the art can make various modifications and improvements without departing from the concept of this application, and these all fall within the protection scope of this application. Therefore, the protection scope of this patent application should be determined by the appended claims.

Claims

1. A clinical trial drug management method characterized by, An application in a clinical trial drug cabinet includes a connected cabinet body and a cabinet door, the interior of the cabinet body and the cabinet door forming a storage space; multiple weighing platforms are fixedly connected to the inner wall of the cabinet body, penetrating the storage space, and each weighing platform is arranged perpendicular to the cabinet door, dividing the storage space into multiple layers of clinical trial drug storage space; each layer of clinical trial drug storage space is equipped with at least one electronic tag reader for scanning electronic tags affixed to clinical trial drugs, the clinical trial drug management method includes: After receiving the list of clinical trial drugs to be placed in the cabinet from the pharmacy system, when receiving the cabinet placement instruction associated with the clinical trial drug to be placed in the cabinet, the system searches for the target storage space of the clinical trial drug to be placed in the cabinet list based on the cabinet placement instruction and provides a prompt. When the electronic tag reader in the storage space scans the electronic tag attached to the clinical trial drug to be placed in the storage space, it reads the clinical trial drug information recorded in the electronic tag; wherein, the storage space is any layer in the multi-layer clinical trial drug storage space; Determine whether the clinical trial drug information of the drug to be placed in the cabinet is included in the clinical trial drug placement list; If the clinical trial drug information of the drug to be placed in the cabinet is not included in the clinical trial drug placement list, an abnormality prompt will be issued; If the clinical trial drug information of the clinical trial drug to be placed in the cabinet is included in the clinical trial drug cabinet list, then after the weighing platform in the cabinet storage space detects an increase in the weight it bears, it is determined whether the target storage space is consistent with the cabinet storage space. If the target storage space is inconsistent with the cabinet storage space, a prompt will be given regarding the target storage space; If the target storage space matches the cabinet storage space, then the clinical trial drug to be cabineted is successfully cabineted.

2. The method of claim 1, wherein, The method further includes: After receiving the list of clinical trial drugs sent by the pharmacy system, the current placement list of the clinical trial drug cabinet is obtained; wherein, the current placement list records the current storage space of all clinical trial drugs in the clinical trial drug cabinet; By comparing the clinical trial drug retrieval list with the current placement list, the retrieval storage space where the clinical trial drug to be retrieved is placed can be determined from all clinical trial drug storage spaces and a prompt can be made. If the weighing platform in the drug retrieval storage space detects a decrease in the weight it carries, the electronic tag reader in the drug retrieval storage space scans the electronic tag attached to the clinical trial drug to be retrieved to read the clinical trial drug information of the clinical trial drug to be retrieved; wherein, the drug retrieval storage space is any layer in the multi-layer clinical trial drug storage space; If the clinical trial drug information is included in the clinical trial drug collection list, then the collection of the clinical trial drug will be successful.

3. The method according to claim 2, characterized in that, The process of comparing the clinical trial drug retrieval list with the current placement list to determine the retrieval storage space for the clinical trial drug to be retrieved among all clinical trial drug storage spaces and providing a prompt includes: After comparing the clinical trial drug retrieval list and the current placement list, if it is determined that a clinical trial drug to be retrieved is placed in a multi-layer clinical trial drug storage space, the clinical trial drug storage space where the clinical trial drug to be retrieved with the closest expiration date is placed will be used as the drug retrieval storage space and a prompt will be made.

4. The method according to claim 2, characterized in that, The method further includes: After comparing the clinical trial drug retrieval list with the current placement list, if it is determined that there are multiple clinical trial drugs to be retrieved in the same layer of clinical trial drug storage space, the retrieval of the clinical trial drug to be retrieved will be successful when the clinical trial drug closest to its expiration date is retrieved.

5. The method according to claim 2, characterized in that, The process of comparing the clinical trial drug retrieval list with the current placement list to determine the retrieval storage space for the clinical trial drug to be retrieved among all clinical trial drug storage spaces and providing a prompt includes: After comparing the clinical trial drug retrieval list and the current placement list, if it is determined that multiple clinical trial drugs to be retrieved are placed in the multi-layer clinical trial drug storage space, the clinical trial drug storage space containing the most clinical trial drugs to be retrieved will be designated as the drug retrieval storage space in real time and a prompt will be given.

6. The method according to claim 1, characterized in that, Each weighing platform includes a carrier plate fixedly connected to the inner wall of the cabinet, a weighing sensor disposed at the bottom of the carrier plate, and an access display disposed on the carrier plate near the cabinet door.

7. The clinical trial drug cabinet according to claim 1, characterized in that, The electronic tag reader is symmetrically arranged on two side walls inside the cabinet, and the two side walls are perpendicular to the weighing platform and the cabinet door.

8. The method according to claim 1, characterized in that, The cabinet is also equipped with a refrigerant, a temperature sensor, a humidity regulator, and a humidity sensor.

9. The method according to claim 8, characterized in that, The cabinet is also provided with a partition that runs through the accommodating space, and the partition is set parallel to the weighing platform. The partition divides the accommodating space into a first accommodating space and a second accommodating space. The cabinet door includes a first cabinet door and a second cabinet door. The first cabinet door is used to open or close the first accommodating space, and the second cabinet door is used to open or close the second accommodating space. An environmental display for displaying temperature and / or humidity is provided at one end of the partition near the cabinet door, and is connected to the temperature sensor and the humidity sensor.

Images